Numerous studies have demonstrated that the expression and activation of IRF family members, including IRF3, IRF5, and IRF7, are significantly increased in systemic autoimmune diseases such as systemic lupus erythematosus (SLE) and Sjögren’s syndrome (SS) (51, 52). This evidence concerns the gene IRF5 and synovial sarcoma.